Report Detail

Request for Sample of this report

Other Global Stereotactic-guided Biopsy Instrument Market Insights, Forecast to 2025

  • RnM2897130
    • |
  • 07 February, 2019
    • |
  • Global
    • |
  • 113 Pages
    • |
  • QYResearch
    • |
  • Other

The global Stereotactic-guided Biopsy Instrument market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Stereotactic-guided Biopsy Instrument market based on company, product type, end user and key regions.

This report studies the global market size of Stereotactic-guided Biopsy Instrument in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Stereotactic-guided Biopsy Instrument in these regions.
This research report categorizes the global Stereotactic-guided Biopsy Instrument market by top players/brands, region, type and end user. This report also studies the global Stereotactic-guided Biopsy Instrument market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
C. R. Bard, Inc. (U.S.)
Becton, Dickinson and Company (U.S.)
Cook Group Incorporated (U.S.)
Devicor Medical Products, Inc., (Leica Biosystems) (Germany)
Argon Medical Devices (U.S.)
B. Braun Melsungen AG (Germany)
Cardinal Health, Inc. (U.S.)
Olympus Corporation (Japan)
Boston Scientific Corporation (U.S.)
FUJIFILM Holdings Corporation (Japan)
INRAD, Inc. (U.S.)
Medtronic plc (Ireland)

Market size by Product
Needle-based Biopsy Instruments
Localization Wires
Procedure Trays
Others
Market size by End User
Breast Biopsy
Lung Biopsy
Colorectal Biopsy
Prostate Biopsy
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Stereotactic-guided Biopsy Instrument market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Stereotactic-guided Biopsy Instrument market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Stereotactic-guided Biopsy Instrument companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Stereotactic-guided Biopsy Instrument submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Stereotactic-guided Biopsy Instrument are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Stereotactic-guided Biopsy Instrument market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Study Coverage

    • 1.1 Stereotactic-guided Biopsy Instrument Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Stereotactic-guided Biopsy Instrument Market Size Growth Rate by Product
      • 1.4.2 Needle-based Biopsy Instruments
      • 1.4.3 Localization Wires
      • 1.4.4 Procedure Trays
      • 1.4.5 Others
    • 1.5 Market by End User
      • 1.5.1 Global Stereotactic-guided Biopsy Instrument Market Size Growth Rate by End User
      • 1.5.2 Breast Biopsy
      • 1.5.3 Lung Biopsy
      • 1.5.4 Colorectal Biopsy
      • 1.5.5 Prostate Biopsy
      • 1.5.6 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Stereotactic-guided Biopsy Instrument Market Size
      • 2.1.1 Global Stereotactic-guided Biopsy Instrument Revenue 2014-2025
      • 2.1.2 Global Stereotactic-guided Biopsy Instrument Sales 2014-2025
    • 2.2 Stereotactic-guided Biopsy Instrument Growth Rate by Regions
      • 2.2.1 Global Stereotactic-guided Biopsy Instrument Sales by Regions
      • 2.2.2 Global Stereotactic-guided Biopsy Instrument Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Stereotactic-guided Biopsy Instrument Sales by Manufacturers
      • 3.1.1 Stereotactic-guided Biopsy Instrument Sales by Manufacturers
      • 3.1.2 Stereotactic-guided Biopsy Instrument Sales Market Share by Manufacturers
      • 3.1.3 Global Stereotactic-guided Biopsy Instrument Market Concentration Ratio (CR5 and HHI)
    • 3.2 Stereotactic-guided Biopsy Instrument Revenue by Manufacturers
      • 3.2.1 Stereotactic-guided Biopsy Instrument Revenue by Manufacturers (2014-2019)
      • 3.2.2 Stereotactic-guided Biopsy Instrument Revenue Share by Manufacturers (2014-2019)
    • 3.3 Stereotactic-guided Biopsy Instrument Price by Manufacturers
    • 3.4 Stereotactic-guided Biopsy Instrument Manufacturing Base Distribution, Product Types
      • 3.4.1 Stereotactic-guided Biopsy Instrument Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Stereotactic-guided Biopsy Instrument Product Type
      • 3.4.3 Date of International Manufacturers Enter into Stereotactic-guided Biopsy Instrument Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Stereotactic-guided Biopsy Instrument Sales by Product
    • 4.2 Global Stereotactic-guided Biopsy Instrument Revenue by Product
    • 4.3 Stereotactic-guided Biopsy Instrument Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Stereotactic-guided Biopsy Instrument Breakdown Data by End User

    6 North America

    • 6.1 North America Stereotactic-guided Biopsy Instrument by Countries
      • 6.1.1 North America Stereotactic-guided Biopsy Instrument Sales by Countries
      • 6.1.2 North America Stereotactic-guided Biopsy Instrument Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Stereotactic-guided Biopsy Instrument by Product
    • 6.3 North America Stereotactic-guided Biopsy Instrument by End User

    7 Europe

    • 7.1 Europe Stereotactic-guided Biopsy Instrument by Countries
      • 7.1.1 Europe Stereotactic-guided Biopsy Instrument Sales by Countries
      • 7.1.2 Europe Stereotactic-guided Biopsy Instrument Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Stereotactic-guided Biopsy Instrument by Product
    • 7.3 Europe Stereotactic-guided Biopsy Instrument by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Stereotactic-guided Biopsy Instrument by Countries
      • 8.1.1 Asia Pacific Stereotactic-guided Biopsy Instrument Sales by Countries
      • 8.1.2 Asia Pacific Stereotactic-guided Biopsy Instrument Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Stereotactic-guided Biopsy Instrument by Product
    • 8.3 Asia Pacific Stereotactic-guided Biopsy Instrument by End User

    9 Central & South America

    • 9.1 Central & South America Stereotactic-guided Biopsy Instrument by Countries
      • 9.1.1 Central & South America Stereotactic-guided Biopsy Instrument Sales by Countries
      • 9.1.2 Central & South America Stereotactic-guided Biopsy Instrument Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Stereotactic-guided Biopsy Instrument by Product
    • 9.3 Central & South America Stereotactic-guided Biopsy Instrument by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Stereotactic-guided Biopsy Instrument by Countries
      • 10.1.1 Middle East and Africa Stereotactic-guided Biopsy Instrument Sales by Countries
      • 10.1.2 Middle East and Africa Stereotactic-guided Biopsy Instrument Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Stereotactic-guided Biopsy Instrument by Product
    • 10.3 Middle East and Africa Stereotactic-guided Biopsy Instrument by End User

    11 Company Profiles

    • 11.1 C. R. Bard, Inc. (U.S.)
      • 11.1.1 C. R. Bard, Inc. (U.S.) Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 C. R. Bard, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 C. R. Bard, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Products Offered
      • 11.1.5 C. R. Bard, Inc. (U.S.) Recent Development
    • 11.2 Becton, Dickinson and Company (U.S.)
      • 11.2.1 Becton, Dickinson and Company (U.S.) Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Becton, Dickinson and Company (U.S.) Stereotactic-guided Biopsy Instrument Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Becton, Dickinson and Company (U.S.) Stereotactic-guided Biopsy Instrument Products Offered
      • 11.2.5 Becton, Dickinson and Company (U.S.) Recent Development
    • 11.3 Cook Group Incorporated (U.S.)
      • 11.3.1 Cook Group Incorporated (U.S.) Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Cook Group Incorporated (U.S.) Stereotactic-guided Biopsy Instrument Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Cook Group Incorporated (U.S.) Stereotactic-guided Biopsy Instrument Products Offered
      • 11.3.5 Cook Group Incorporated (U.S.) Recent Development
    • 11.4 Devicor Medical Products, Inc., (Leica Biosystems) (Germany)
      • 11.4.1 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Stereotactic-guided Biopsy Instrument Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Stereotactic-guided Biopsy Instrument Products Offered
      • 11.4.5 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Recent Development
    • 11.5 Argon Medical Devices (U.S.)
      • 11.5.1 Argon Medical Devices (U.S.) Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Argon Medical Devices (U.S.) Stereotactic-guided Biopsy Instrument Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Argon Medical Devices (U.S.) Stereotactic-guided Biopsy Instrument Products Offered
      • 11.5.5 Argon Medical Devices (U.S.) Recent Development
    • 11.6 B. Braun Melsungen AG (Germany)
      • 11.6.1 B. Braun Melsungen AG (Germany) Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 B. Braun Melsungen AG (Germany) Stereotactic-guided Biopsy Instrument Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 B. Braun Melsungen AG (Germany) Stereotactic-guided Biopsy Instrument Products Offered
      • 11.6.5 B. Braun Melsungen AG (Germany) Recent Development
    • 11.7 Cardinal Health, Inc. (U.S.)
      • 11.7.1 Cardinal Health, Inc. (U.S.) Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Cardinal Health, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Cardinal Health, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Products Offered
      • 11.7.5 Cardinal Health, Inc. (U.S.) Recent Development
    • 11.8 Olympus Corporation (Japan)
      • 11.8.1 Olympus Corporation (Japan) Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Olympus Corporation (Japan) Stereotactic-guided Biopsy Instrument Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Olympus Corporation (Japan) Stereotactic-guided Biopsy Instrument Products Offered
      • 11.8.5 Olympus Corporation (Japan) Recent Development
    • 11.9 Boston Scientific Corporation (U.S.)
      • 11.9.1 Boston Scientific Corporation (U.S.) Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Boston Scientific Corporation (U.S.) Stereotactic-guided Biopsy Instrument Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Boston Scientific Corporation (U.S.) Stereotactic-guided Biopsy Instrument Products Offered
      • 11.9.5 Boston Scientific Corporation (U.S.) Recent Development
    • 11.10 FUJIFILM Holdings Corporation (Japan)
      • 11.10.1 FUJIFILM Holdings Corporation (Japan) Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 FUJIFILM Holdings Corporation (Japan) Stereotactic-guided Biopsy Instrument Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 FUJIFILM Holdings Corporation (Japan) Stereotactic-guided Biopsy Instrument Products Offered
      • 11.10.5 FUJIFILM Holdings Corporation (Japan) Recent Development
    • 11.11 INRAD, Inc. (U.S.)
    • 11.12 Medtronic plc (Ireland)

    12 Future Forecast

    • 12.1 Stereotactic-guided Biopsy Instrument Market Forecast by Regions
      • 12.1.1 Global Stereotactic-guided Biopsy Instrument Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Stereotactic-guided Biopsy Instrument Revenue Forecast by Regions 2019-2025
    • 12.2 Stereotactic-guided Biopsy Instrument Market Forecast by Product
      • 12.2.1 Global Stereotactic-guided Biopsy Instrument Sales Forecast by Product 2019-2025
      • 12.2.2 Global Stereotactic-guided Biopsy Instrument Revenue Forecast by Product 2019-2025
    • 12.3 Stereotactic-guided Biopsy Instrument Market Forecast by End User
    • 12.4 North America Stereotactic-guided Biopsy Instrument Forecast
    • 12.5 Europe Stereotactic-guided Biopsy Instrument Forecast
    • 12.6 Asia Pacific Stereotactic-guided Biopsy Instrument Forecast
    • 12.7 Central & South America Stereotactic-guided Biopsy Instrument Forecast
    • 12.8 Middle East and Africa Stereotactic-guided Biopsy Instrument Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Stereotactic-guided Biopsy Instrument Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Summary:
      Get latest Market Research Reports on Stereotactic-guided Biopsy Instrument . Industry analysis & Market Report on Stereotactic-guided Biopsy Instrument is a syndicated market report, published as Global Stereotactic-guided Biopsy Instrument Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Stereotactic-guided Biopsy Instrument market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$4,900.00
      		$7,350.00
      		$9,800.00
      		3,787.70
      		5,681.55
      		7,575.40
      		4,561.90
      		6,842.85
      		9,123.80
      		748,181.00
      		1,122,271.50
      		1,496,362.00
      		413,560.00
      		620,340.00
      		827,120.00
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo